At week 8, clinical remission and improvements in endoscopy were higher in the NCB-02 group compared to the placebo, but the difference did not reach statistical significance [ 52 ].
← all excerpts
The Role of Plant-Derived Natural Products in the Management of Inflammatory Bowel Disease-What Is the Clinical Evidence So Far?
1
—
—